A new study published in the UEG Journal found that poor oral health is associated with a 75% increased risk of hepatocellular carcinoma (HCC), the most common type of liver cancer.
News
FDA ‘yes’ for Emgality in Cluster Headache
The US Food and Drug Administration (FDA) announced the approval of the first treatment of episodic cluster headaches to reduce the frequency of attacks, Eli Lilly’s Emgality (galcanezumab-gnlm).
Record Number of Cancer Drugs Released in 2018
A new IQVIA report showed that in 2018, a record number of anticancer drugs were launched in the US for 17 indications.
New NICE Guideline to Help Identify Suspected Neurological Conditions
The National Institute for Health and Care Excellence (NICE) has introduced a new guideline that offers comprehensive information on neurological conditions to help health care non-specialists identify people who should be referred for specialist evaluation and care.
FDA is Pushing for Stronger Warnings about Insomnia Medications
The US food and drug administration (FDA) has announced that it will now require stronger warnings about rare but serious incidents involving some insomnia medications such as Lunesta (eszopiclone), Sonata (zaleplon), and Ambien (zolpidem).
